nanotechnology biotechnology TSCA
FIFRA
nanotechnology

CHEMICAL PRODUCT DEVELOPMENT AND DEFENSE
biotechnology
TSCA
FIFRA
nanotechnology
ABOUT ACTA EU STAFF ARTICLES NEWS KEY REGULATORY DEVELOPMENTS FAQs CONTACT HOME
biotechnology
nanotech


CHEMICAL PRODUCT DEVELOPMENT AND DEFENSE
A CONSULTING FIRM ESTABLISHED TO CONTROL THE SPIRALING COSTS AND INEFFICIENCIES ENCOUNTERED BY CLIENTS SEEKING APPROVALS TO MARKET CHEMICALS, PRODUCTS OF BIOTECHNOLOGY, NANOTECHNOLOGY, AND MEDICAL DEVICE PRODUCTS. THE ACTA GROUP, L.L.C. MANAGES PRODUCTS FROM CONCEPT TO APPROVAL, UTILIZING THE SKILLS AND EXPERIENCE OF PROFESSIONALS WHO HAVE WORKED IN THE SPECIFIC PRODUCT AREAS IN GOVERNMENT AND INDUSTRY.
TSCA
 nanotech
biotech
TSCA

nanotechnology
Acta EU professionals, working closely with their U.S. affiliates, The Acta Group, L.L.C. and Bergeson & Campbell, P.C., offer a full range of REACH regulatory services.

The Acta Group, L.L.C. has been certified as a business owned and controlled by a woman by the National Women Business Owners Corporation (NWBOC).

 

nanotech


 

 

 

 

 
nanotechnology
The Acta Group, L.L.C. has entered into an exclusive collaborative partnership with Life Plus LLC to provide expertise on Asia's chemical product and biotechnology-related product registration process.
More information. 

The Acta Group, L.L.C. has entered into a strategic alliance with Caleb Management to provide REACH services. More information.

 biotech